StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Research analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of CALA opened at $0.01 on Wednesday. The company’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.02. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.